107 research outputs found

    Elastase-2, a tissue alternative pathway for angiotensin II generation, plays a role in circulatory sympathovagal balance in mice

    Get PDF
    In vitro and ex vivo experiments indicate that elastase-2 (ELA-2), a chymotrypsin-serine protease elastase family member 2A, is an alternative pathway for angiotensin II (Ang II) generation. However, the role played by ELA-2 in vivo is unclear. We examined ELA-2 knockout (ELA-2KO) mice compared to wild-type (WT) mice and determined whether ELA-2 played a role in hemodynamics [arterial pressure (AP) and heart rate (HR)], cardiocirculatory sympathovagal balance and baroreflex sensitivity. The variability of systolic arterial pressure (SAP) and pulse interval (PI) for evaluating autonomic modulation was examined for time and frequency domains (spectral analysis), whereas a symbolic analysis was also used to evaluate PI variability. In addition, baroreflex sensitivity was examined using the sequence method. Cardiac function was evaluated echocardiographically under anesthesia. The AP was normal whereas the HR was reduced in ELA-2KO mice (425 ± 17 vs. 512 ± 13 bpm from WT). SAP variability and baroreflex sensitivity were similar in both strains. The LF power from the PI spectrum (33.6 ± 5 vs. 51.8 ± 4.8 nu from WT) and the LF/HF ratio (0.60 ± 0.1 vs. 1.45 ± 0.3 from WT) were reduced, whereas the HF power was increased (66.4 ± 5 vs. 48.2 ± 4.8 nu from WT) in ELA-2KO mice, indicating a shift toward parasympathetic modulation of HR. Echocardiographic examination showed normal fractional shortening and an ejection fraction in ELA-2KO mice; however, the cardiac output, stroke volume, and ventricular size were reduced. These findings provide the first evidence that ELA-2 acts on the sympathovagal balance of the heart, as expressed by the reduced sympathetic modulation of HR in ELA-2KO mice

    Results of the BiPo-1 prototype for radiopurity measurements for the SuperNEMO double beta decay source foils

    Get PDF
    The development of BiPo detectors is dedicated to the measurement of extremely high radiopurity in 208^{208}Tl and 214^{214}Bi for the SuperNEMO double beta decay source foils. A modular prototype, called BiPo-1, with 0.8 m2m^2 of sensitive surface area, has been running in the Modane Underground Laboratory since February, 2008. The goal of BiPo-1 is to measure the different components of the background and in particular the surface radiopurity of the plastic scintillators that make up the detector. The first phase of data collection has been dedicated to the measurement of the radiopurity in 208^{208}Tl. After more than one year of background measurement, a surface activity of the scintillators of A\mathcal{A}(208^{208}Tl) == 1.5 μ\muBq/m2^2 is reported here. Given this level of background, a larger BiPo detector having 12 m2^2 of active surface area, is able to qualify the radiopurity of the SuperNEMO selenium double beta decay foils with the required sensitivity of A\mathcal{A}(208^{208}Tl) << 2 μ\muBq/kg (90% C.L.) with a six month measurement.Comment: 24 pages, submitted to N.I.M.

    Spectral modeling of scintillator for the NEMO-3 and SuperNEMO detectors

    Full text link
    We have constructed a GEANT4-based detailed software model of photon transport in plastic scintillator blocks and have used it to study the NEMO-3 and SuperNEMO calorimeters employed in experiments designed to search for neutrinoless double beta decay. We compare our simulations to measurements using conversion electrons from a calibration source of 207Bi\rm ^{207}Bi and show that the agreement is improved if wavelength-dependent properties of the calorimeter are taken into account. In this article, we briefly describe our modeling approach and results of our studies.Comment: 16 pages, 10 figure

    Two-loop O(GF2MH4){\rm O}\left(G_F^2M_H^4\right) corrections to the fermionic decay rates of the Higgs boson

    Full text link
    We calculate the dominant O(GF2MH4){\rm O}\left(G_F^2M_H^4\right) two-loop electroweak corrections to the fermi\-onic decay widths of a heavy Higgs boson in the Standard Model. Use of the Goldstone-boson equivalence theorem reduces the problem to one involving only the physical Higgs boson HH and the Goldstone bosons w±w^\pm and zz of the unbroken theory. The two-loop corrections are opposite in sign to the one-loop electroweak corrections, exceed the one-loop corrections in magnitude for MH>1114 GeVM_H>1114\ {\rm GeV}, and increase in relative magnitude as MH2M_H^2 for larger values of MHM_H. We conclude that the perturbation expansion in powers of GFMH2G_FM_H^2 breaks down for MH1100 GeVM_H\approx 1100\ {\rm GeV}. We discuss briefly the QCD and the complete one-loop electroweak corrections to Hbbˉ,ttˉH\rightarrow b\bar{b}, \,t\bar{t}, and comment on the validity of the equivalence theorem. Finally we note how a very heavy Higgs boson could be described in a phenomenological manner.Comment: 24 pages, RevTeX file, 4 figures in a separate compressed uuencoded Postscript file or available by mail on request. Fig. 1 not included see Figs. 1, 2 in Phys. Rev. D 48, 1061 (1993

    Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors

    Get PDF
    New federal regulations allow HIV-positive individuals to be live kidney donors; however, potential candidacy for donation is poorly understood given the increased risk of end-stage renal disease (ESRD) associated with HIV infection. To better understand this risk, we compared the incidence of ESRD among 41 968 HIV-positive participants of North America AIDS Cohort Collaboration on Research and Design followed for a median of 5 years with the incidence of ESRD among comparable HIV-negative participants of National Health and Nutrition Examination III followed for a median of 14 years. We used risk associations from multivariable Cox proportional hazards regression to derive cumulative incidence estimates for selected HIV-positive scenarios (no history of diabetes, hypertension, AIDS, or hepatitis C virus coinfection) and compared these estimates with those from similarly selected HIV-negative scenarios. For 40-year-old HIV-positive individuals with health characteristics that were similar to those of age-matched kidney donors, viral load &lt;400 copies/mL, and CD4+ count ≥500 cells/μL, the 9-year cumulative incidence of ESRD was higher than that of their HIV-negative peers, yet still low: 2.5 versus 1.1 per 10 000 among white women, 3.0 versus 1.3 per 10 000 among white men, 13.2 versus 3.6 per 10 000 among black women, and 15.8 versus 4.4 per 10 000 among black men. HIV-positive individuals with no comorbidities and well-controlled disease may be considered low-risk kidney donor candidates
    corecore